Background and Aims: Sporadic hepatitis E is an emerging indigenous disease in
| INTRODUC TI ON
Hepatitis E is a worldwide disease with a global incidence of about 20 million cases of acute hepatitis each year and estimated 70 000 deaths.
1 Among adults in Asia, the Middle East and Africa it proved to be the most or second most important cause of acute clinical hepatitis.
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On the contrary, hepatitis E virus (HEV) was rarely identified in industrialized countries; affected individuals have usually travelled to an endemic area a short time ago. 3 In the past few years, there has been an increasing number of reports on hepatitis E cases in persons who had not travelled abroad, but were infected at home in Europe or the USA. 4, 5 There exist at least four genotypes of HEV that are pathogenic for humans. 3 In Europe and the USA, there is an increasing number of cases caused by genotype 3. 6 Genotypes 1, 2 and 3 may induce acute, even fatal acute, liver failure. However, genotype 3 can run a chronic course especially in immunocompromised individuals. 7 Most of the reported cases with a chronic disease occurred in the transplant setting when patients received solid organ transplants. [8] [9] [10] [11] A strong association between HEV infection after transplantation and graft rejection was shown.
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The histopathology of acute hepatitis E has been described in several publications, [13] [14] [15] [16] [17] whereas the histopathology of chronic hepatitis E has been described in case reports, but has not been evaluated in detail so far. 8, 11, [18] [19] [20] [21] [22] Therefore, we analysed the liver biopsies from a cohort of 19 patients with chronic hepatitis E.
| MATERIAL S AND ME THODS
Liver biopsies from 19 patients (17 male, 2 female; aged 23-66 years) from four hospitals (Vienna, Hanover, Hamburg, Cologne), of whom 17 had undergone solid organ transplantation (6 liver transplantations, 3 kidney transplantations, 4 double-lung transplantations and 4 heart transplantations) were obtained (see Tables 1 and 3 and Table   S1 .). In the six patients that received liver transplants, two had cirrhosis because of alcoholic liver disease, three had end-stage liver disease and cirrhosis because of chronic hepatitis C and one woman had cirrhosis with autoimmune hepatitis. One human immunodeficiency virus (HIV)-negative patient had CD4 impairment and the second individual without transplantation had received longstanding steroid therapy because of ulcerative colitis. Other liver diseases as autoimmune hepatitis, viral hepatitis A, B and C, steatohepatitis, alcoholic disease, calcineurin inhibitor toxicity, rejection and biliary duct diseases as primary sclerosing cholangitis and primary biliary cholangitis or obstruction were excluded by chemical and laboratory findings, nucleic acid testing and clinical data. All patients were positive for HEV in the serum for more than 6 months and positive for
HEV in the liver when tested by PCR after RNA extraction. So in all patients, clinical data and histopathology showed chronic hepatitis when characterized by the classic definition of a hepatitis lasting at least for 6 months. All patients had given their written consent for the biopsy. Liver biopsies from five patients undergoing bariatric surgery and negative for HEV infection served as negative controls.
The study was approved by the Ethics Commission of the Medical University of Vienna (1382/2016).
| Serology and Biochemistry
Laboratory tests were done for aspartate and alanine transaminase (AST and ALT), gamma-glutamyl transferase (GGT), alkaline phosphatase (AP) and total bilirubin (see Tables 1 and 3 
| Histological evaluation
The histological evaluation of the inflammatory activity and the stage of fibrosis were performed by applying the Ishak grading and score. 23 When observing that many of the biopsies displayed some degree of cholangitis, we set up a semi-quantitative score for the bile duct lesions:
Grade 1: Some lymphocytes and/or polymorphonuclear (PMN) leucocytes between bile duct epithelia (analogue reactive cholangitis).
Grade 2: Lymphoepithelial lesions in bile ducts with degenerative changes of the epithelia.
Key points
• This is the first comprehensive report on histopathology of chronic hepatitis E (CHE) in a larger cohort of 19 patients substantiated by PCR in liver tissue and localization of hepatitis E virus (HEV) by immunohistochemistry (IHC).
• First description of patterns of HEV staining in CHE in hepatocytes with cytoplasmic and nuclear reaction and in bile ducts with cholangitis in a larger series.
• Cholangitis seems to be an intrinsic lesion in CHE because of the presence of HEV in bile ducts. 
| Immunohistochemistry
Biopsies were immunohistochemically stained with two different HEV antibodies using a Universal DAB Detection Kit (Ventana, 
| RE SULTS
The 
| Histopathology
The overall histological activity showed a mean Ishak score of 6 Tables 2 and 3 ). Bile duct epithelia were TA B L E 1 Mean (minimum-maximum) age at time of biopsy and biochemical data by transplanted organ infiltrated by lymphocytes and a significant number of PMN leucocytes, which were also present to a lesser degree in zone I of the There was some cellular cholestasis in zone III. Steatosis was not observed, and no granulomas were found. Endothelitis was absent.
Fibrosis was evident in all cases with a mean stage of 2. The portal tracts were enlarged with or without short septae (score 2) in seven patients. Fibrosis with bridging septae (score 3) was noted in one patient (see Figure 1 , panel C) and one patient had incomplete cirrhosis (score 5). By trichrome stain the collagen tissue was restricted to portal tracts and septae in most cases; however, in three biopsies, there was a conspicuous fibrosis pattern with central vein sclerosis and pericellular fibrosis in the central area as also seen in alcoholic or non-alcoholic steatohepatitis. There was no substantial difference of histopathology in patients who had received liver transplants and those who had received other solid organs.
| Immunohistochemistry
All biopsies were positive for staining with the anti-HEV antibodies.
The pattern at the single cell level displayed a granular staining in the cytoplasm of the hepatocytes and some nuclei were also positive, as reported earlier. [24] [25] [26] At the lobular level, a focal staining pattern was observed, sometimes extending into areas of the whole lobule.
The amount of positive hepatocytes varied between 10% and 60%
for antibodies against ORF2 and 40 and 50% with antibodies against ORF3. Bile ducts were positive as well. Remarkably, larger bile ducts did not show a significant cholangitis, whereas smaller bile ducts were affected by considerable, even destructive cholangitis (see Figure 1 , panel D and E). In the bile ducts, the whole epithelia stained positive. Hepatocytes were negative for antibodies against cytokeratin 7, whereas all bile duct epithelia were positive. Liver biopsies from our control patients negative for HEV in the serum showed a mild background as been observed also by Lenggenhager, 25 but no specific staining in immunohistochemistry with ORF2 and ORF3
antibodies (see Figure S1 ). An antibody reaction was interpreted as specific when the staining was bound to cell structures and subcellular structures, whereas an unspecific staining was sometimes noted at the rim of the section or background not bound to cell organelles.
| D ISCUSS I ON
The infection with HEV genotype 3 as an indigenous disease in Europe and the USA has been diagnosed with an increasing frequency in the recent years. 3, 6, 27, 28 Transmission by blood transfusions and blood products has recently been reported in several cases. 29, 30 Whereas most of the cases run an acute self-limiting hepatitis, the disease may evolve into a chronic course in immunocompromised patients, 2  0  2  2  2  2  2  1  3   1  1  3  2  1  3  2  1  3   2  0  2  2  1  1  2  0  3   3  1  2  3  2  2  2  0  3   3  0  3  3  3  3  3  1  3   2  0  2  2  2  2  2  1  2   2  0  2  3  1  2  2  0  2   2  2  3  3  1  3  3  1 Positive especially in the setting of solid organ transplantation. [8] [9] [10] [11] 27 Our patients received immunosuppression therapy (see Table 3 ). Also patients with HIV infection bear the risk to develop a chronic disease. 20, 31, 32 The occurrence of chronic hepatitis E was also reported in an immunocompetent patient. 33 Recently, Ingiliz P et al described a patient with persistence of an HEV infection, although the immunosuppressant therapy was terminated. 34 We defined chronic hepatitis E in agreement with the classic recommendation of a course longer than 6 months although in the new guideline of EASL a chronic hepatitis E can be diagnosed already after 3 months of starting the therapy.
TA B L E 2 Histological evaluation of the 19 biopsies arranged by grade of cholangitis
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The incidence of chronic hepatitis E in transplant recipients was estimated at about 66% 36 ; however, this frequency is based on a single study, and more data are needed.
The histopathology of acute hepatitis E caused by genotype 3 has been described in several reports [13] [14] [15] [16] [17] ; however, a detailed evaluation of the chronic lesions is lacking so far; there are only five short statements, 8, 11, [18] [19] [20] and description of two further patients.
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Therefore, we analysed the histopathology of biopsies from 19 patients with chronic hepatitis E, 17 of whom had undergone solid organ transplantation, one HIV-negative patient had CD4 lymphocyte deficiency and there was one patient who received longstanding steroid therapy because of ulcerative colitis.
The histopathology of chronic hepatitis fits into the pattern of chronic viral hepatitis with enlarged infiltrated portal tracts, lobular hepatitis to a variable extend and fibrosis of portal tracts extending as fibrotic septae into the parenchyma. There are no pathognomonic features as are ground glass hepatocytes for chronic hepatitis B. However, there were some lesions that were more pronounced than in the other types of chronic viral hepatitis. One is the obvious active cholangitis that surpassed a reactive cholangitis in type B and C hepatitis as described in the literature. 15, 16, 37 Four biopsies of 19
showed grade 1 and ten displayed grade 2 cholangitis; five biopsies showed a florid active inflammation of the bile ducts with necrosis In summary, chronic hepatitis E shows a histopathological pattern consistent with a chronic hepatitis of viral origin. There are no pathognomonic features for HEV genotype 3; however, biopsies display a cholangitis that is active and sometimes destructive seemingly because of the presence of the virus in bile duct epithelia.
Peculiar lesions with an increased number of PMN leucocytes are also present.
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